Sugar company EID Parry (India) announced Q1FY23 results: Consolidated: The consolidated revenue from operations for the quarter ended 30th June 2022, was Rs. 7,146 Crore registering an increase of 64% in comparison to the corresponding quarter of previous year of Rs. 4,354 Crore. Earnings before depreciation, interest and taxes (EBITDA) and before exceptional items for the quarter ended 30th June 2022 was Rs. 754 Crore registering an increase of 53% in comparison to the corresponding quarter of previous year profit of Rs. 494 Crore. Consolidated profit after tax and noncontrolling interest was Rs. 276 Crore compared to Rs. 133 Crore in the corresponding quarter of previous year. Standalone: The Standalone revenue from operations for the quarter ended 30th June 2022 was Rs. 722 Crore in comparison to the corresponding quarter of previous year of Rs. 450 Crore. Profit before depreciation, interest and taxes (EBITDA) and before exceptional item for the quarter was Rs. 11 Crore compared to a loss of Rs. 4 Crore in corresponding quarter of the previous year. Standalone profit after tax for the quarter was Rs. 13 Crore as against a loss of Rs. 33 Crore in the corresponding quarter of previous year. Mr; S. Suresh, Managing Director commenting on the standalone results mentioned that "Operating performance of the Company during the quarter was significantly better than the corresponding quarter of the previous year on account of better volumes and realisation in sugar, power and distillery. The Company crushed around 2.69 LMT in current quarter as against 1.46 LMT in the corresponding quarter of the previous year. Higher power tariff helped in better profitability of the power segment. Sale of Land and Buildings in Puducherry unit and the Plant and Machinery in Pettaivaithalai factory was completed during the Q1 22-23. The Consolidated Nutraceutical operations registered a Loss before Interest and Tax of Rs. 3.64 Crore as against loss of Rs. 0.43 Crore corresponding quarter of previous year. This was mainiy attdbutable to the increase in marketing expenses due to B2C launch in the US." Result PDF
Conference Call with EID Parry (India) Management and Analysts on Q4FY22 Performance and Outlook. Listen to the full earnings transcript.
Sugar company EID Parry (India) Sugar declares Q4FY22 result: Consolidated The consolidated revenue from operations for the quarter ended 31st March 2022, was Rs 5,667 crore registering an increase of 46% in comparison to the corresponding quarter of previous year of Rs 3,877 crore. Earnings before depreciation, interest, taxes and exceptional items (EBITDA) for the quarter ended 31st March 2022 was Rs 707 crore against corresponding quarter of previous year of Rs 321 crore. Consolidated profit after tax was Rs 429 crore compared to Rs 62 Crore in corresponding quarter of previous year. The consolidated revenue from operations for the year ended 31st March 2022 was Rs 23,528 crore registering an increase of 27% against previous year of Rs 18,556 crore. Earnings before depreciation, interest, taxes and exceptional items (EBITDA) for the year ended 31st March 2022 was Rs 2,629 crore registering an increase of 18% against previous year of Rs 2,219 crore. Consolidated profit after tax was Rs 1,574 crore against previous year of Rs 1,000 crore. Standalone The Standalone revenue for the quarter ended 31st March 2022 was Rs 922 crore in comparison to the corresponding quarter of previous year of Rs 564 crore. Earnings before depreciation, interest, taxes and exceptional items (EBITDA) for the quarter ended were Rs 309 crore in comparison to the corresponding quarter of previous year of Rs 294 crore. Standalone profit after tax for the quarter is Rs 225 crore as against corresponding quarter of previous year Rs 169 crore. The Standalone revenue from operations for the year ended 31st March 2022 was Rs 2,496 crore against previous year of Rs 2,024 crore and Earnings before depreciation, interest, taxes and exceptional items (EBITDA) for the year ended was Rs 492 crore against previous year of Rs 556 crore. Standalone Profit after tax was Rs 284 crore as against Rs 865 crore in the previous year. The profit after tax for the year ended 31st March 2022 includes exceptional loss of Rs 14 crore arising from sale of Plant and Machinery in Puducherry unit as compared to exceptional gain of Rs 715 crore in the previous year arising from sale of 4% stake in Coromandel International Limited net off Impairment and Pudukottai asset transfer expenses. Mr S. Suresh, Managing Director commenting on the standalone results for the year mentioned as follows: "The Company has performed better than the last year on account of better realisation in Sugar and Power, Distillery expansion in Bagalkot and higher cane volumes and recoveries. Overall cane crush during the year was 50.21 LMT as compared to 39.69 LMT during the previous year. Overall sugar sales increased from 4.00 LMT in the previous year to 4.95 LMT during the current year which included, exports of 1.69 LMT of sugar in the current year as against 1.15 LMT in the previous year. Company focussed on the sweating of assets and expansion in core areas while maintaining the optimum cost levels. The transfer of 4500TCD capacity from Pudukottai to Haliyal was completed during the year and 1.45 LMT cane was crushed using the transferred capacity during the interim period. The Company had disposed the plant and machinery in Puducherry unit. Distillery expansion of 60 KLPD facility in Bagalkot became functional during the year. Also, the Company has initiated 120 KLPD grain based ethanol project in Sankili which should come into operation in Q4 of FY 2022-23. All the above initiatives should augur well for the company in the future years. The debt reduction programme helped in reduction ofthe finance cost from Rs 93 crore in FY 2020-21 to Rs 46 crore in the current financial year. Standalone Nutraceuticals division registered reduction in profit from Rs 5 crore in previous year to Rs 4 crore in the current year due to reduced production on account of inclement weather. However, the Consolidated Nutraceuticals segment registered a revenue growth of 9% from Rs 254 crore in previous year to Rs 277 crore during the current year." Result PDF
Conference Call with EID Parry (India) Ltd. Management and Analysts on Q3FY22 Performance and Outlook. Listen to the full earnings transcript.
Conference Call with EID Parry (India) Management and Analysts on Q3FY22 Performance and Outlook. Listen to the full earnings transcript.
Sugar company EID Parry (India) declares Q3FY22 result: The revenue from operations for the quarter ended 31st 'December 2021 was Rs. 686 Crore in comparison to the corresponding quarter of previous year of Rs. 439 Crore. Earnings before . depreciation, interest and taxes (EBITDA) and before exceptional items for the quarter was Rs: 72 Crore in comparison to the corresponding quarter of previous year of Rs. 31 Crore. Standalone Profit after tax for the quarter was Rs. 18 Crore as against Rs. 339 Crore in corresponding quarter of previous year The revenue from operations for the nine months ended 31st December 2021 was Rs. 1,574 Crore in comparison to the corresponding period of previous year of Rs. 1,460 Crore. Earnings before depreciation, interest and taxes (EBITDA) and before exceptional item for the nine months ended 31st December 2021 was Rs. 183 Crore as against Rs. 262 Crore in corresponding period of previous year. Standalone Profit after tax for the nine months ended 31st December 2021 was Rs. 58 Croreas against Rs. 696 Crore in corresponding period of previous year. The consolidated revenue from operations for the quarter ended 31st December 2021 was Rs. 6,529 Crore, registering an increase of 39% in comparison to the corresponding quarter of previous year of Rs. 4,701 Crore. Earnings before depreciation, interest and taxes (EBITDA) and before exceptional item for the quarter ended 31st December 2021 was Rs. 656 Crore registering an increase of 17% in comparison to the corresponding quarter of previous year of Rs. 559 Crore. Consolidated profit after tax was Rs. 395 Crore compared to Rs. 245 Crore in corresponding quarter of previous year . The consolidated revenue from operations for the nine months ended 31st December 2021 was Rs. 17,862 Crore as against corresponding period ofthe previous year of Rs. 14,679 Crore. Earnings before depreciation, interest and taxes (EBITDA) and before exceptional item for the nine months ended 31st December 2021 was Rs. 1,922 Crore against corresponding period of the previous year of Rs. 1,897 Crore. Consolidated profit after tax was Rs. 1,145 Crore as against Rs. 938 Crore in corresponding period of the previous year. Mr. S Suresh, Managing Director commenting on the standalone results mentioned that "The Company performed better than the corresponding quarter of previous year on account of better realisation and higher volume of exports and alcohol sales. Firming up of global sugar prices helped in higher exports. The debt reduction measures have helped in reduction of finance cost. Cane crush for the Company is expected to be better than previous sugar year. The Company continues to focus on sweating the assets along with cost and cash management. During the quarter the company has disposed the Plant and Machinery in Puducherry unit. Standalone Nutraceuticals division incurred a loss of Rs. 0.85 Crore for the quarter compared to a profit of Rs. 1.67 Crore in the corresponding quarter of previous year due to reduced production on account of inclement weather. However, the Standalone Nutraceuticals segment registered a 24% growth in Profit for the nine months ended 31st December 2021 as compared to the corresponding period of the previous year." Result PDF